 sodium 2-methylpropan-2-olate |
| 1-(4-Pyridinyl)-2-Propanone |
| 2-HYDROXY-3-METHOXY-3,3-DIPHENYLPROPANOICACID |
| D-Pantothenic Acid Sodium Salt |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
| Benzoic acid,4-[(4-methyl-1-piperazinyl)methyl]-, hydrochloride (1:2) |
| IMIQUIMOD |
| Dabigatran etexilate intermediates 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER |
| Dabigatran etexilate intermediates N-(4-Cyanophenyl)glycine |
| Dabigatran etexilate intermediates 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester |
| Ezetimibe intermediates (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| Ezetimibe intermediates 4-4-fluorophenyliminomethylphenol |
| Ticagrelor intermediates 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid |
| Ticagrelor intermediates (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium |
| Ticagrelor intermediates 4,6-Dichloro-2-(propylthio)pyrimidin-5-amine |
| Ticagrelor |
| Posaconazole intermediates (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
| Posaconazole intermediates 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one |
| Salmeterol |
| Isavuconazole intermediates 1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole |
| Isavuconazole intermediates (2S,3R) - 3 - (2,5 - difluorophenyl) - 3 - hydroxy - 2 - methyl - 4 - (1H - 1,2,4 - triazol - 1 - yl)butanenitrile |
| Isavuconazole intermediates |
| Platinum intermediates TRANS-CYCLOBUTANE-1,2-DICARBOXYLIC ACID |
| Platinum intermediates 1,2-Cyclobutanedicarboxamide,trans- (9CI) |
| Platinum intermediates trans-1,2-Bis(aminomethyl)cyclobutane |
| Prucalopride intermediates 4-Piperidinamine, 1-(3-methoxypropyl)-, hydrochloride (1:2) |
| Prucalopride intermediates 7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-n-[1-(3-methoxypropyl)-4-piperidinyl]-, hydrate (1:1) |
| Prucalopride intermediates 7-Benzofurancarboxamide,4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
| Reggae fini intermediates 2-CHLORO-5-AMINEBENZOTRIFLUORIDE |
| Reggae fini intermediates 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide |
| Reggae fini intermediates 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-, monohydrochloride |
| Sola Feeney intermediates |
| Sola Feeney intermediates |
| Sola Feeney intermediates |
| 4,4,5,5,5-Pentafluoropentanol |
| [S,S]-2,8-DIAZABICYCLO[4,3,0]NONANE |
| methyl 2,4-dibromobutyrate |
| Tributyl(vinyl)tin |
| allyltributylstannane |
| Ethyl potassium malonate |
| Diethyl ketomalonate |
| 2,2,2-trifluoro-acetamid |
| 2-Aminodiphenylamine |
| N,N-Dimethylphenylenediamine |
| Methyl 5-bromovalerate |
| 5-(Bromoacetyl)salicylaldehyde |
| Prucalopride succinate |
| 5-NitrothioPHene-2-carboxylic acid |
| 5,6-Diamino-2-picoline |
| 4H-1-Benzopyran-4-one, 8-amino-2-(1H-tetrazol-5-yl)-, monohydrochloride |
| 3-2-spiroadamatane-4-methoxy-4-3-phosphoryloxy-phenyl-1,2-dioxetane) Dioxetane |
| 2-(Aminomethyl)piperidine |
| (R)-(-)-1,2,3,4-Tetrahydro-1-naphthylamine |
| (S)-1-Amino-1,2,3,4-tetrahydronaphthalene |
| 4-AMINOTETRAHYDROPYRAN |
| 4-(Aminomethyl)piperidine |
| 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one |
| 6-Hydroxy-7-Methoxyquinazoline-4-One |
| 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate |
| (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide |
| 2-AMINO-N-(2-CHLORO-6-METHYLPHENYL)THIAZOLE-5-CARBOXAMIDE |
| 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride |
| N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
| Imatinib mesylate) |
| 6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4(1H)-ONE) |
| ERLOTINIB HCL |
| ERLOTINIB |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
| 5-FORMYLFURAN-2-BORONICACID |
| 3-Chloro-4-(3-fluorobenzyloxy)aniline |
| 4-(4-Aminophenoxy)-N-methyl-2-pyridinecarboxamide |
| SORAFENIB TOSYLATE |
| Sorafenib |
| |
| Sulfur trioxide trimethylamine |
| C15H22N2O3.C2H2O4 |
| 4,7-Dihydroxy-3-(3-nitrobenzyl)-2-oxo-2h-1-benzopyran |
| Naphthalene,1-cyclopropyl-4-isothiocyanato- |
|
| Products------Posaconazole intermediates 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one |
| Products： |
Posaconazole intermediates 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one |
| Cas No.: |
184177-83-1 |
| Molecular Formula： |
C30H35N5O3 |
| Molecular Weight： |
513.63 |
|
|
